Luka Dončić Remains Out With Left Hamstring Strain; Week-to-Week Tag Continues

Luka Dončić is currently sidelined with a left leg hamstring strain, carrying a week-to-week designation as of May 9, 2026 — putting this squarely in playoff territory where that label deserves careful unpacking. The grade of this hamstring strain is inferred, not confirmed by any publicly disclosed imaging. "Week-to-week" language is most consistent with a Grade 2 partial injury at the myotendinous junction — the kind that sidelines a player for 3–6 weeks under standard management. A Grade 1 strain typically resolves in 1–2 weeks and rarely earns a week-to-week tag at this stage; a Grade 3 tear would almost certainly carry a more definitive timeline or a surgical flag. So Grade 2 is the working clinical read here, with the caveat that hamstring grades in the NBA are frequently managed conservatively and re-injury risk is the dominant concern regardless of initial severity.

The playoff context is everything. It's May, which means the normal calculus on "week-to-week" shifts considerably. In the regular season, week-to-week on a hamstring often means the team is being cautious with a player they don't need to rush. In the playoffs, it means the medical staff and coaching staff are actively negotiating the line between biological readiness and competitive urgency — and that line gets pushed harder in May than at any other point on the calendar. The hamstring is the NBA's most reinjured soft tissue; coming back too early on a partial strain, particularly one involving the myotendinous junction, dramatically elevates re-tear risk. A re-injury at this stage of a playoff run would be far more damaging than sitting an extra 5–7 days.

The biology on a Grade 2 hamstring strain sets a floor of 3–6 weeks for full tissue recovery. If this injury is recent — and the lack of a specific injury date in public reporting makes exact elapsed time unclear — that floor is the binding constraint regardless of what Dončić's functional testing shows. Functional clearance consistently precedes biological healing on hamstring injuries, which is precisely why the reinjury rate is elevated in athletes who return based on performance metrics alone. With Dallas's playoff positioning in the balance, expect the team to manage this conservatively in public framing while privately weighing every available clinical data point. Any return within 1–2 weeks from now would represent the aggressive end of what the biology supports and should be watched closely for signs of compensation or re-aggravation.